Could genome sequencing newborns give valuable insight or do harm? That’s the question US doctors are trying to answer in a pioneering trial starting this month. Robert Green, associate professor of medicine at Brigham and Women’s Hospital, is quoted. Alan Beggs, Sir Edwin and Lady Manton Professor of Pediatrics at Boston Children’s Hospital, is mentioned.
Beth Israel Deaconess Medical Center, a Framingham biotechnology company, and an international research group are joining in a research initiative aimed at improving the diagnosis and treatment for one of the deadliest forms of cancer. James Moser, associate professor of surgery at Beth Israel Deaconess Medical Center, is quoted.
A handful of weight-loss and sports supplements contain a never-before-tested ingredient that’s closely related to amphetamines – not the plant extract indicated on their label, according to a new study. Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, led the research.
Why should people do research on how to make the world’s most dangerous viruses and bugs more lethal? The answer varies tremendously depending on who is asking and for what purpose the research is taking place. While experts differ in their views on how and where such work should be done, there is wide agreement that the barriers to entry for new biological creations, including ones that could kill millions of people, are decreasing. George Church, Robert Winthrop Professor of Genetics, is quoted.
Popular weight-loss and workout supplements on sale in hundreds of vitamin shops across the nation contain a chemical nearly identical to amphetamine, the powerful stimulant, and pose dangers to the health of those who take them, according to a new study. Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, is the lead author of the study.
Claire McCarthy, assistant professor of pediatrics at Boston Children’s Hospital, authored this blog post about behavioral therapy for preschoolers with ADHD.
Beth Israel Deaconess Medical Center, a Framingham biotechnology company, and an international research group are joining in a research initiative aimed at improving the diagnosis and treatment for one of the deadliest forms of cancer. James Moser, associate professor of surgery at Beth Israel Deaconess Medical Center, is quoted.
A handful of weight-loss and sports supplements contain a never-before-tested ingredient that’s closely related to amphetamines not the plant extract indicated on their label, according to a new study. Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, led the research.
Taking the financial burden of organ donation off the shoulders of donors and their families is not only more fair, but it might also lead to more organs for transplant, experts say. Mildred Solomon, professor of anesthesia at Children’s Hospital Boston, is quoted.
